IKBKB and atherosclerosis: Thus, IKKβ/NF-κB signalling plays a complex role in inflammation and atherogenesis by driving both pro- and anti-inflammatory processes, and the outcome of NF-κB inhibition on atherosclerosis seems strongly dependent on the targeted cell type.